Biomodex Plans 3-D Organ-Printing Plant for Preoperation Preparation in Boston

By Conor Hale

Biomodex has raised $15 million in early funding and is aiming to open a new 3-D printing facility outside Boston to build patient-specific synthetic organs so surgeons can practice and plan for complex operations.

The series A round adds to the company’s $3.5 million in the bank and was led by the European investment firms Idinvest Partners and InnovAllianz, with participation from previous investors LBO France and Inserm Transfert Initiative.

Biomodex’s INVIVOTECH system 3-D prints